Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 322 (RNA5SP322)

Target
RNA5SP322
Molecular classification
Pseudogene, rRNA pseudogene, Non-coding RNA pseudogene
01

Overview

RNA, 5S ribosomal pseudogene 322 is a processed pseudogene of the 5S ribosomal RNA gene family. 5S rRNA is a component of the large ribosomal subunit essential for protein synthesis. As a pseudogene, RNA5SP322 arose via gene duplication or retrotransposition but has acquired mutations or lacks regulatory elements needed for proper function; thus, it does not produce a functional RNA or protein product in the cell. Unlike active 5S rRNA genes, which are transcribed and participate in the ribosome, pseudogenes like RNA5SP322 are generally transcriptionally silent and biologically inert, though some pseudogenes have been implicated in gene regulation or disease when transcribed, typically as non-coding RNAs. No evidence supports such a function for RNA5SP322.

Other names
RN5S322RNA, 5S ribosomal 322RNA5SP322
02

Mechanism of action

None. No drugs act on this pseudogene.

03

Biological functions

None established for this specific pseudogene; parent 5S rRNA gene is involved in ribosome structure and function, but this pseudogene lacks such activity
04

Disease associations

Other (no direct disease relevance established for RNA5SP322 specifically; some pseudogenes are associated with disease mechanisms or transcriptional regulation, but no evidence links this one to clinical outcomes)
05

Safety considerations

None. Not a functional gene or target
06

Interacting drugs

None known. Pseudogenes are not drug targets
07

Biomarkers

None established for patient selection or efficacy monitoring related to RNA5SP322

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 322 (RNA5SP322).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 322 (RNA5SP322).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call